Decreased inflammatory response in Toll-like receptor 2 knockout mice is associated with exacerbated Pneumocystis pneumonia

Microbes and Infection

Volumn 10, Issue 4, 2008, Pages 334-341

  Wang, Shao Hung ^a   Zhang, Chen ^b   Lasbury, Mark E ^b   Liao, Chung Ping ^b   Durant, Pamela J ^b   Tschang, Dennis ^b   Lee, Chao Hung ^b  

^a I SHOU UNIVERSITY   (Taiwan)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Pneumocystis; Toll like receptor 2

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MACROPHAGE INFLAMMATORY PROTEIN; MESSENGER RNA; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME ACTIVATION; FEMALE; HISTOPATHOLOGY; HYPOTHESIS; INFLAMMATION; LUNG INJURY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOCYSTIS; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

ANIMALS; FEMALE; INFLAMMATION; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

MUS; PNEUMOCYSTIS;

EID: 42649116405     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.12.014     Document Type: Article

References (30)

1. Sepkowitz K.A. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin. Infect. Dis. 34 (2002) 1098-1107
2. Stringer J.R., Beard C.B., Miller R.F., and Wakefield A.E. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg. Infect. Dis. 8 (2002) 891-896
3. Keely S.P., Fischer J.M., Cushion M.T., and Stringer J.R. Phylogenetic identification of Pneumocystis murina sp. nov., a new species in laboratory mice. Microbiology 150 (2004) 1153-1165
4. Morris A., Wachter R.M., Luce J., Turner J., and Huang L. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 17 (2003) 73-80
5. Lund F.E., Schuer K., Hollifield M., Randall T.D., and Garvy B.A. Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody. J. Immunol. 171 (2003) 1423-1430
6. Hamacher J., Sadallah S., Schifferli J.A., Villard J., and Nicod L.P. Soluble complement receptor type 1 (CD35) in bronchoalveolar lavage of inflammatory lung diseases. Eur. Respir. J. 11 (1998) 112-119
7. Kedzierska K., Azzam R., Ellery P., Mak J., Jaworowski A., and Crowe S.M. Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J. Clin. Virol. 26 (2003) 247-263
8. Ezekowitz R.A., Williams D.J., Koziel H., Armstrong M.Y., Warner A., Richards F.F., and Rose R.M. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351 (1991) 155-158
9. Steele C., Marrero L., Swain S., Harmsen A.G., Zheng M., Brown G.D., Gordon S., Shellito J.E., and Kolls J.K. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 β-glucan receptor. J. Exp. Med. 198 (2003) 1677-1688
10. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int. Immunol. 17 (2005) 1-14
11. Zhang C., Wang S.H., Lasbury M.E., Tschang D., Liao C.P., Durant P.J., and Lee C.H. Toll-like receptor 2 mediates alveolar macrophage response to Pneumocystis murina. Infect. Immun. 74 (2006) 1857-1864
12. Zheng M., Shellito J.E., Marrero L., Zhong Q., Julian S., Ye P., Wallace V., Schwarzenberger P., and Kolls J.K. CD4+T cell-independent vaccination against Pneumocystis carinii in mice. J. Clin. Invest. 108 (2001) 1469-1474
13. Rudmann D.G., Preston A.M., Moore M.W., and Beck J.M. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-gamma and type 1 and 2 TNF receptor genes. J. Immunol. 161 (1998) 360-366
14. Zhang J., Zhu J., Imrich A., Cushion M., Kinane T.B., and Koziel H. Pneumocystis activates human alveolar macrophage NF-κB signaling through mannose receptors. Infect. Immun. 72 (2004) 3147-3160
15. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., and Underhill D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197 (2003) 1107-1117
16. Tachado S.D., Zhang J., Zhu J., Patel N., Cushion M., and Koziel H. Pneumocystis-mediated IL-8 release by macrophages requires coexpression of mannose receptors and TLR2. J. Leukoc. Biol. 81 (2007) 205-211
17. Dennehy K.M., and Brown G.D. The role of the beta-glucan receptor dectin-1 in control of fungal infection. J. Leukoc. Biol. 82 (2007) 253-258
18. Ding K., Shibui A., Wang Y., Takamoto M., Matsuguchi T., and Sugane K. Impaired recognition by Toll-like receptor 4 is responsible for exacerbated murine Pneumocystis pneumonia. Microbes Infect. 7 (2005) 195-203
19. Wright T.W., Gigliotti F., Finkelstein J.N., McBride J.T., An C.L., and Harmsen A.G. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J. Clin. Invest. 104 (1999) 1307-1317
20. Gigliotti F., Crow E.L., Bhagwat S.P., and Wright T.W. Sensitized CD8+T cells fail to control organism burden but accelerate the onset of lung injury during Pneumocystis carinii pneumonia. Infect. Immun. 74 (2006) 6310-6316
21. Swain S.D., Wright T.W., Degel P.M., Gigliotti F., and Harmsen A.G. Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice. Infect. Immun. 72 (2004) 5722-5732
22. Sherman M.P., Loro M.L., Wong V.Z., and Tashkin D.P. Cytokine- and Pneumocystis carinii- induced l-arginine oxidation by murine and human pulmonary alveolar macrophages. J. Protozool. 38 (1991) 234S-236S
23. Downing J.F., Kachel D.L., Pasula R., and Martin II W.J. Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by l-arginine- and tumor necrosis factor-dependent mechanisms. Infect. Immun. 67 (1999) 1347-1352
24. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci. 75 (2004) 639-653
25. Shellito J.E., Kolls J.K., Olariu R., and Beck J.M. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model. J. Infect. Dis. 173 (1996) 432-439
26. Hidalgo H.A., Helmke R.J., German V.F., and Mangos J.A. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect. Immun. 60 (1992) 1-7
27. Saijo S., Fujikado N., Furuta T., Chung S.H., Kotaki H., Seki K., Sudo K., Akira S., Adachi Y., Ohno N., Kinjo T., Nakamura K., Kawakami K., and Iwakura Y. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8 (2007) 39-46
28. Yoneda K., and Walzer P.D. Interaction of Pneumocystis carinii with host lungs: an ultrastructural study. Infect. Immun. 29 (1980) 692-703
29. Bedrossian C.W. Ultrastructure of Pneumocystis carinii: a review of internal and surface characteristics. Semin. Diagn. Pathol. 6 (1989) 212-237
30. Sistek C.J., Wordell C.J., and Hauptman S.P. Adjuvant corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS patients. Ann. Pharmacother. 26 (1992) 1127-1133